Ocular Hypertension (OHT) Treatments

Find Ocular Hypertension (OHT) Treatments

Medications for Ocular Hypertension (OHT)

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Ocular Hypertension (OHT).

Found 15 Approved Drugs for Ocular Hypertension (OHT)

Timolol

Brand Names
Timoptic-XE, Betimol, Timoptic, Timolol GFS, Istalol

Timolol

Brand Names
Timoptic-XE, Betimol, Timoptic, Timolol GFS, Istalol
TIMOPTIC Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Latanoprost

Brand Names
Xelpros, Iyuzeh, Xalatan

Latanoprost

Brand Names
Xelpros, Iyuzeh, Xalatan
XELPROS (latanoprost ophthalmic emulsion)

Hydrchloride

Brand Names
Salagen, Qlosi, VUITY

Hydrchloride

Brand Names
Salagen, Qlosi, VUITY
Pilocarpine hydrochloride tablets, USP are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's syndrome.

Cosopt

Generic Name
Dorzolamide

Cosopt

Generic Name
Dorzolamide
Dorzolamide hydrochloride and timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time). The IOP-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day. Dorzolamide hydrochloride and timolol maleate ophthalmic solution is a carbonic anhydrase inhibitor with a beta-adrenergic receptor blocking agent indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers., The IOP-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution twice daily was slightly less than that seen with the concomitant administration of 0.5% timolol twice daily, and 2% dorzolamide three times daily. ( 1 )

Bimatoprost

Brand Names
Lumigan, Latisse, Durysta

Bimatoprost

Brand Names
Lumigan, Latisse, Durysta
LUMIGAN ® (bimatoprost ophthalmic solution)
Showing 1-5 of 15
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances